| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |